Owned and operated by a cf veteran 
Baba Kahn is the founder and owner of Red Leaf Research Labs. A Canadian Armed Forces veteran, former police officer and international security professional, he specializes in peptide operations and weapons systems.
Role at Red Leaf Research Labs
Kahn owns and oversees Red Leaf’s end-to-end manufacturing process. His responsibilities include international affairs, factory oversight, international business relationships, laboratory documentation, importing and exporting, and coordination of teams operating in the countries where his companies conduct business.
Industry experience
Kahn’s experience in the research-chemical sector dates to 2005. Beginning in 2010, his work included serving emergency-services organizations. In 2025, he expanded Red Leaf into ecommerce.
His peptide expertise is operational and technical. It is grounded in international manufacturing oversight, factory operations, laboratory experience, supplier evaluation, analytical documentation, importing and exporting, and long-standing relationships with international companies.
Military, policing and security background
As a Canadian Armed Forces veteran and former police officer, Kahn brings experience in technical systems, procedural discipline, documentation and risk management to Red Leaf’s operations. His weapons-systems background is separate from Red Leaf’s research-peptide activities.
Clinical ventures and scope
Outside Red Leaf, Kahn has ownership interests in medical clinics and works with medical directors through separate ventures. He does not present himself as a physician or a substitute for qualified medical care. These clinical ventures are operationally separate from Red Leaf Research Labs.
Articles and podcasts
Kahn contributes operational and technical commentary on peptide manufacturing, international supply chains, analytical testing, supplier accountability, importing and exporting, and developments in the research-peptide marketplace. His commentary is not medical advice and does not provide dosing or treatment instructions.
Long-form commentary, interviews and podcasts may also be published through The Black Dragon, a separately operated editorial platform. Commercial relationships and ownership interests should be disclosed where relevant.
Research-use-only position
Red Leaf products remain strictly for qualified laboratory research. They are not supplied or presented for therapeutic, cosmetic, human or animal use. Readers can review Red Leaf’s testing documentation standards, legal disclaimer and contact information.